Mark is president and CEO of Children's Hospital Association, representing over 200 children’s hospitals and major pediatric programs with a mission to improve child health through innovation in care, education and research. CHA advances these aims by leading and supporting national collaboration in public policy and pediatric practice improving the access, quality and costs of care for children.
Prior to joining CHA, Mark was a management consultant with Kurt Salmon, where he served as the firm’s executive chairman, responsible for over 2,000 professionals working across five continents in six languages. His professional work in both adult academic and pediatric medicine has been recognized as among the best in the country, and he has advised most of the U.S. News & World Report “Best” medical centers and children's hospitals. Mark has been named among the nation’s “Most Influential Consultants” by Consulting Magazine and as one of the "5 Healthcare Leaders to Know" by Becker's Review. He is a regular presenter on the future of health care and cited in such media as the New York Times, Wall Street Journal, Politico and National Public Radio.
Mark currently serves on the boards of the Children’s Hospital Association, the Council of Teaching Hospitals and Health Systems of the AAMC, the Coalition to Protect America’s Health Care, the National Foundation to End Child Abuse and Neglect, OpenNotes, an organization advancing greater patient engagement in their own care, and Virtual PICU Systems, where he is past chairman of the board. He serves on the advisory boards of the Child and Adolescent Health Measurement Initiative at the Johns Hopkins University, the University of Michigan’s CMS national quality initiative and the New York University Sala Institute, with a mission to integrate pediatric care across a large academic teaching hospital. Mark is a former trustee and past chairman of the board of overseers of the UCLA Health System, a former director and past deputy chairman of the board of Management Consulting Group, a public London-listed company, and a former director and past chairman of the board of Kurt Salmon Associates.
Mark's academic training includes a Master of Science in pharmacology from The Ohio State University and a Master of Business Administration from Indiana University. He is based in Washington, D.C.